VI. REFERENCES BIBLIOGRAPHIQUES

Allan J.S., Coligan J.E., Barin F., McLane M.F., Sodroski J.G., Rosen C.A., Haseltine W.A., Lee T.H., and Essex M. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science, 228, 1091-1094 (1985).

Andreassen H., Bohr H., Boht J., Brunak S., Bugge T., Cotterill R.M., Jacobsen C., Lautrup B., and Petersen S.B. Analysis of the secondary structure of the human immunodeficiency virus (HIV) proteins p17, gp120 and gp41 by computer modeling based on neural network methods.J. Acquir. Immune Defic. Syndr., 3, 615-622 (1990).

Barré-Sinoussi F., Chermann J.C., Rey F., Nugeyre M.T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vezinet-Brun F., Rouzioux C., Rozenbaum W., and Montagnier L. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science, 220, 868-871 (1983).

Baltimore D. RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature, 226, 1209-1211 (1970).

Barin F., McLane M.F., Allan J.S., Lee T.H., Groopman J.E., and Essex M. Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Science, 228, 1094-1096 (1985).

Bernstein H.B., Tucker S.P., Kar S.R., McPherson S.A., McPherson D.T., Dubay J.W., Lebowitz J., Compans R.W., and Hunter E. Oligomerization of the hydrophobic heptad repeat of gp41. J. Virol., 69, 2745-2750 (1995).

Brasseur R., Cornet B., Vandenbranden M., and Ruysschaert J.M. Mode of insertion into a lipid membrane of the N-terminal HIV gp41 peptide segment. AIDS Res. Hum. Retroviruses, 4, 83-90 (1988).

Broder C.C., and Dimitrov D.S. HIV and the 7-transmembrane domain receptors. Pathobiology, 64, 171-179 (1996).

Bost K.L., Hahn B.H., Saag M.S., Shaw G.M., Weigent D.A., and Blalock J.E. Individuals infected with HIV possess antibodies against IL-2. Immunology, 65, 611-615 (1988).

Boyer V., Desgranges C., Trabaud M.A., Fischer E., and Kazatchkine M.A. Complement mediates human immunodeficiency virus type 1 infection of a human T-cell line in a CD4 and antibody-independent fashion. J. Exp. Med., 173, 1151-1158 (1991).

Bullough P.A., Hughson F.M., Skehel J.J., and Wiley D.C. Structure of influenza haemagglutinin at the pH of membrane fusion.Nature, 371, 37-43 (1994).

Chambers P., Pringle C.R., and Easton A.J. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J. Gen. Virol., 71, 3075-3080 (1990).

Chan D.C., Fass D., Berger J.M., and Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell, 89, 263-273 (April 1997).

Chanh T.C., Dreesman G.R., Kanda P., Linette G.P., Sparrow J.T., Ho D.D., and Kennedy R.C. Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBOJ, 5, 3065-3071 (1986).

Chen C.-H., Matthews T.J., McDanal C.B., Bolognesi D.P., and Greenberg M.L. A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion. J. Virol., 69, 3771-3777 (1995).

Chen S.S., Ferrante A.A., and Terwilliger E.F. Characterization of an envelope mutant that interferes with viral infectivity. Virology, 226, 260-268 (1996).

Chen Y.-H., Ebenblicher C., Vornhagen R., Schulz T.F., Steindl F., Böck G., Katinger H., and Dierich M.P. HIV-1 gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line H9. AIDS, 6, 533-539 (1992).

Consonni R., Limiroli R., Longhi R., Manera E., Vecchio G., Ragona L., Siccardi A.G., and Zetta L. NMR and CD studies on the conformation of a synthetic peptide containing epitopes of the human immunodeficiency virus 1 transmembrane protein gp41. Biopolymers, 38, 423-435 (1996).

Crick F.H.C. The packing of a-helices: simple coiled coils. Acta cryst., 6, 689-697 (1953).

D'Souza M.P., and Harden V.A. Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research. Nature Med., 2, 1293-1300 (1996).

Dalgleish A.G., Beverley P.C., Clapham P.R., Crawford D.H., Greaves M.F., and Weiss R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (London), 312, 763-767 (1984).

Delwart E.L. Retroviral envelope glycoproteins contain a "leucine zipper"-like repeat. AIDS Res. Hum. Retroviruses, 11, 323-325 (1990).

Doms R.W., Earl P.L., and Moss B. The assembly of the HIV-1 env glycoprotein into dimers and tetramers. Adv. Exp. Med. Biol., 300, 203-219 (1991).

Doms R.W., Earl P.L., Chakrabati S., and Moss B. Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus env proteins posses a fuctionnaly conserved assembly domain. J. Virol., 64, 3537-3540 (1990).

Dubay J., Roberts S.J., Brody B., and Hunter E. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity. J. Virol., 66, 4748-4756 (1992).

Earl P.L., Broder C.C., Doms R.W., and Moss B. Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein. J. Virol., 71, 2674-2684 (1997).

Earl P.L., Broder C.C., Long D., Lee S.A., Peterson J., Chakrabarti S., Doms R.W., and Moss B. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. J. Virol., 68, 3015-3026 (1994).

Earl P.L., Doms R.W., and Moss B. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA, 87, 648-652 (1990).

Ebenbichler C.F., Stoiber H., Schneider R., Patsch J.R., and Dierich M. P. The human immunodeficiency virus type 1 transmembrane gp41 protein is a calcium-binding protein and interacts with the putative second-receptor molecules in a calcium-dependent manner.J. Virol., 70, 1723-1728 (1996).

Ebenbichler C.F., Thielens N.M., Vornhagen R., Marschang P., Arlaud G.J., and Dierich M.P. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmebrane glycoprotein gp41. J. Exp. Med., 174, 1417-1424 (1991).

Fass D., Harrison S.C., and Kim P.S. Retrovirus envelope domain at 1,7 Å resolution. Nature Structural Biology, 3-5, 465-469 (1996).

Freed E.O., Delwart E.L., Buchschacher G.L., Jr, and Panganiban A.T. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity.Proc. Natl. Acad. Sci. USA, 89, 70-74 (1992).

Freed E.O., Myers D.J., and Risser R. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc. Natl. Acad. Sci. USA, 87, 4650-4654 (1990).

Gabuzda D., Olshevsky U., Bertani P., Haseltine W.A., and Sodroski J. Identification of membrane anchorage domains of the HIV-1 gp160 envelope glycoprotein precursor. J. Acquir. Defic. Syndr., 4, 34-40 (1991).

Gallaher W.R., Ball J.M., Garry R.F., Griffin M.C., and Montelaro R.C. A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res. Hum. Retroviruses, 5, 431-440 (1989).

Gallaher William R. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus.Cell, 50, 327-328 (1987).

Gelderblom H.R., Hausmann E.H., Ozel M., Pauli G., and Koch M.A. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology, 156, 171-176 (1987).

Gnann J.W. Jr, Schwimmbeck P.L., Nelson J.A.,Truax A.B., and Oldstone M.B. Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus.J. Infect. Dis., 156, 261-267 (1987a).

Gnann J.W. Jr, Nelson J.A., and Oldstone M.B. Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus. J. Virol., 61, 2639-2641 (1987b).

Golding H., Robey F.A., Gates F.T. 3d, Linder W., Beining P.R., Hoffman T., and Golding B. Identification of homologous regions in human immunodeficiency virus I gp41 hman MHC class II beta 1 domain. Monoclonal antibodies against the gp41-derived peptide and patientssera react with native HLA class antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. J. Exp. Med., 167, 914-923 (1988)

Harbury P.B., Kim P.S., and Alber T. Crystal structure of an isoleucine-zipper trimer. Nature, 371, 80-83 (1994).

Harbury P.B., Zhang T., Kim P.S., and Alber T. A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. Science, 262, 1401-1407 (1993).

Helseth E., Olshevsky U., Gabuzda D., Ardman B., Haseltine W., and Sodroski J. Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion. J. Virol., 64, 6314-6318 (1990).

Henderson L.A., and Qureshi M.N. A peptide inhibitor of human immunodeficiency virus infection binds to novel human cells surface polypeptides. J. Biol.Chem., 268, 15291-15297 (1993).

Hill C.P., Worthylake D., Bancroft D.P., Christensen A.M., and Sundquist W.I. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc. Natl. Acad. Sci. USA, 93, 3099-3104 (1996).

Huang R.T., Rott R., and Klenk H.D. Influenza viruses cause hemolysis and fusion of cells. Virology, 110, 243-247 (1981).

Hughson Frederik M. Structural characterization of viral fusion proteins. Curr. Biol., 5, 265-274 (1995).

Jiang S., Lin K., Strick N., and Neurath R. HIV-1 inhibition by a peptide. Nature, 365, 113 (1993a).

Jiang S., Lin K., Strick N., and Neurath R. Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein gp41. Biochem. Biophys. Res.Commun., 195, 533-538 (1993b).

Klasse P.J., Pipkorn R., and Blomberg J. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects. Proc. Natl. Acad. Sci. USA, 85, 5225-5229 (1988).

Klatzmann D.E., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J.C., and Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature, 312, 767-768 (1984).

Kowalski M., Potz J., Basiripour L., Dorfman T., Goh W.C., Terwilliger E., Dayton A., Rosen C., Haseltine W., and Sodroski J. Fuctional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science, 237, 1351-1355 (1987).

Lawless M.K., Barney S., Guthrie K.I., Bucy T.B., Petteway S.R., Jr., and Merutka G. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41. Biochemistry, 35, 13697-13708 (1996).

Lodge R., Gottlinger H;, Gabuzda D., Cohen E.A., and Lemay G. The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. >J. Virol., 68, 4857-4861 (1994).

Lu M., Blacklow S.C., and Kim P.S. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nature Structural Biology, 2, 1075-1082 (1995).

Maeda T., Kawasaki K., Ohnishi S. Interaction of influenza virus hemagglutinin with target membrane lipids is a key step in virus-induced hemolysis and fusion at pH 5.2. Proc. Natl. Acad. Sci. USA., 78, 4133-4137 (1981).

McClure M.O., Marsh M., and Weiss R.A. Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism. EMBOJ, 7, 513-518 (1988).

Muster T., Steindl F., Purtscher M., Trkola A., Klima A., Himmler G., Ruker F., and Katinger H. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J.Virol., 67, 6642-6647 (1993).

Narvanen A., Korkolainen M., Kontio S., Suni J., Turtianen S., Partanen P., Soos J., Vaheri A., and Huhtala M.L. Highly immunoreactive antigenic site in a hydrophobic domain of HIV-1 gp41 which remains undetectable with conventional methods. AIDS, 2, 119-123 (1988).

Neurath A.L., Lin K., Strick N., and Jiang S. Two partially overlapping antiviral peptides from th external portion of HIV type 1 glycoprotein 41, adjoining the transmembrane region, affect the glycoprotein 41 fusion domain. AIDS Res. Hum. Retroviruses, 11, 189-190 (1995).

Neurath A.L., Strick N., and Jiang S. Synthetic peptides and anti-peptide antibodies as probes to study interdomain interactions involved in virus assembly: the envelope of human immunodeficiency virus (HIV-1). Virology, 188, 1-13 (1992).

Neurath A.R., Strick N., Taylor P., Rubinstein P., and Stevens C.E. Search for epitope-specific antibody responses to the human immunodeficiency virus (HIV-1) envelope glycoproteins signifying resistance to disease development. AIDS Res. Hum. Retroviruses, 6, 1183-1192 (1990).

Oldstone M.B.A., Tishon A., Lewicki H., Dyson J.H., Feher V.A., Assa-Munt N., and Wright P.E. Mapping the anatomy of the immunodominant domain of the human Immunnodeficiency virus gp41 transmembrane protein: peptide conformation analysis using monoclonal antibodies and proton nuclear magnetic resonance spectroscopy. J. Virol., 65, 1727-1734 (1991).

Pinter A., Honnen W.J., Tilley S.A., Bona C., Zaghouani H., Gorny M.K., and Zolla-Pazner S. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J. Virol., 63, 2674-2679 (1989).

Poumbourios P., Wilson K.A., Center R.J., El Ahmar W., and Kemp B.E. Human immunodeficiency virus type 1 envelope glycoprotein oligomerisation requires the gp41 amphipathic a-helical/leucine zipper-like sequence. J. Virol., 71, 2041-2049 (1997).

Poumbourios P., El Ahmar W., McPhee D.A., and Kemp B.E. Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure. J. Virol.,69, 1209-1218 (1995).

Qureshi N.M., Coy D.H., Garry R.F., and Henderson L.A. Characterization of a putative cellular receptor for HIV-1 transmembrane glycoprotein using synthetic peptides. AIDS, 4, 553-558 (1990).

Rabenstein M.D., and Shin Y.-K. HIV-1 gp41 tertiary structure studied by EPR spectroscopy. Biochemistry, 35, 13922-13928 (1996).

Rabenstein M., and Shin Y.-K. A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled coil formation. Biochemistry, 34, 13390-13397 (1995).

Rafalski M., Lear J.D., and DeGrado W.F. Phospholipid interactions of synthetic peptides representing the N-terminus of the HIV gp41. Biochemistry, 29, 7917-7922 (1990).

Reisinger E.C., Vogetseder W., Berzow D., Kofler D., Bitterlich G., Lehr H.A., Wachter H., and Dierich M.P. Complement-mediated enhancement of HIV-1 infection of the monoblatsoid cell line U937. AIDS, 4, 961-965 (1990).

Rimsky-Clarke L., Shugars D.C., Chen Chin H., and Matthews T.J. Studies of synthetic peptide and recombinant protein models of the HIV-1 gp41 ectodomain. Dixieme Colloque des Cent Gardes, 153-158 (1995).

Robey W.G., Safai B., Oroszlan S., Arthur L.O., Gonda M.A., Gallo R.C., and Fischinger P.J. Characterisation of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science, 228, 593-595 (1985).

Sattentau Q. J., and Moore J. P. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med., 174, 407-415 (1991).

Schawaller M., Smith G. E., Skehel J.J., and Wiley D.C. Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV. Virology, 172, 367-369 (1989).

Sharova N.K., and Bukrinskaia A.G. The characteristics of the interaction of the proteins comprising the virions of the human immunodeficiency virus type 1. Vopr.Virusol., 35, 202-206 (1990).

Shugars D.C., Wild C.T., Greenwell T.K., and Matthews T.J. Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human imunnodeficiency virus type 1 transmembrane protein gp41. J. Virol., 70-5, 2982-2991 (1996).

Slepushkin V.A., Andreev S.M., Sidorova M.V., Melikyan G.B., Grigoriev V.B., Chumakov V.M., Grinfeldt A.E., Manukyan R.A., and Karamov E.V. Investigation of human immunodeficiency virus fusion peptides. Analysis of interremations between their structure and function. AIDS Res. Hum. Retroviruses,8, 9-18 (1992).

Slepushkin V.A., Melikyan G.B., Sidorova M.V., Chumakov V.M., Andreev S.M., Manukyan R.A., and Karamov E.V. Interaction of human immunodeficiency virus (HIV-1) fusion peptides with artificial lipid membranes. Biochem. Biophys. Res. Commun., 172, 952-957 (1990).

Solder B.M., Schulz T.F., Hengster P., Lower J., Larcher C., Bitterlich G., Kurth R., Wachter H, and Dierich M.P. HIV and HIV-infected cells differentially activate the human complement system independent of antibody. Immunol. Lett., 22, 135-145 (1989a).

Solder B.M., Reisinger E.C., Köfler D., Bitterlich G., Kurth R., Wachter H, and Dierich M.P. Complement receptors another port of entry for HIV. Lancet, 2, 271 (1989b).

Stein B.S., Gowda S.D., Lifson J.D., Penhallow R.C., Bensch K.G., and Engleman E.G. pH-independant HIV entry into CD4-positive cells via virus envelope fusion to the plasma membrane. Cell, 49, 659-668 (1987).

Temin H.M., and Mizutani S. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature, 226, 1211-1213 (1970).

Thielens N.M., Bally I.M., Ebenblicher C.F., Dierich M.P., and Arlaud G.J. Further characterization of the interaction between the C1q subcomponent of human C1 and the transmembrane envelope glycoprotein gp41 of HIV-1. J. Immunol., 151, 6583-6592 (1993).

Thomas D. J., Wall J. S., Hainfeld J. F., Kaczorek M., Booy F. P., Trus B. L., Eiserling F. A., and Steven A. C. gp160, the envelope glycoprotein of human immunodeficiency virus type 1, is a dimer of 125-kilodalton subunits stabilized through interactions between their gp41 domains. J. Virol., 65, 3797-3803 (1991).

Veronese F.D., DeVico A.L., Copeland T.D., Oroszian S., Gallo R.C., and Sarngadharan M.G. Characterisation of gp41 as the transmembrane protein coded by the HTLVIII/LAV envelope gene. Science, 229, 1402-1405 (1985).

Wain-Hobson S., Sonigo P., Danos O., Cole S., and Alizon M. Nucleotide sequence of the AIDS virus: LAV. Nature, 226, 1211-1213 (1985).

Weiss C.D., Levy J.A., and White J.M. Oligomeric structure of gp120 on infectious human immunodeficiency virus type 1 particles. J. Virol., 64, 5674-5677 (1990).

Weissenhorn W., Calder L.J., Dessen A., Laue T., Skehel J.J., and Wiley D.C. Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in Escherichia coli. Proc. Natl. Acad. Sci. USA, 94, 6065-6069 (June 1997b).

Weissenhorn W., Dessen A., Harrison S.C., Skehel J.J., and Wiley D.C. Atomic structure of the ectodomain from HIV-1 gp41. Nature, 387, 426-430 (May 1997a).

Weissenhorn W., Wharthon S.A., Calder L.J., Earl P.L., Moss B., Aliprandis E., Skehlel J.J., and Wiley D.C. The ectodomain of HIV-1 env subunit gp41 forms a soluble, a-helical, rod like oligomer in the absence of gp120 and the N-terminal fusion peptide. EMBOJ, 15, 1507-1514 (1996).

White J., Matlin K., and Helenius A. Cell fusion by Semliki Forest, influenza, and vesicular stomatitis. J. Cell. Biol., 89, 674-679 (1981).

Wild C., Greenwell T., Shugars D., Rimsky-Clarke L., and Matthews T.J. The inhibitory activity of an HIV type 1 peptides correlates with its ability to interact with a leucine zipper structure. AIDS Res. Hum. Retroviruses, 11, 323-325 (1995).

Wild C., Dubay J.W., Greenwell T., Baird T., Jr., Oas T.G., McDanal C., Hunter E., and Matthews T. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proc. Natl. Acad. Sci. USA, 91, 12676-1680 (1994a).

Wild C., Shugars D., Greenwell T., McDanal C., and Matthews T. Peptides corresponding to a predictive a-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA, 91, 9770-9774 (1994b).

Wild C., Oas T., Greenwell T., and Matthews T. A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus mediated cell-cell fusion. AIDS Res. Hum. Retroviruses,9, 1051-1053 (1993).

Wild C., Oas T., McDanal C., Bolognesi D., and Matthews T. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation betwen solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA, 89, 10537-10541 (1992).

Wilkinson D. HIV-1: cofactors provide the entry keys. Curr. Biol., 6, 1051-1053 (1996).

Xu J.-Y., Gorny M.K., Palker T., Karwowska S., and Zolla-Pazner S.Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies. J.Virol.,65, 4832-4838 (1991).